FNCH
Finch Therapeutics Group Inc

745
Mkt Cap
$12.85M
Volume
3,907.00
52W High
$16.10
52W Low
$2.00
Price
$8.00
FNCH Fundamentals
Prev Close
$8.00
Open
$8.00
50D MA
$11.93
Beta
0.20
Avg. Volume
7,798.50
Loading...
Loading...

About

Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Finch Therapeutics Group Inc?
What is the 52-week high for Finch Therapeutics Group Inc?
What is the 52-week low for Finch Therapeutics Group Inc?
What is Finch Therapeutics Group Inc stock price today?
What was Finch Therapeutics Group Inc stock price yesterday?
What is the 50-day moving average of Finch Therapeutics Group Inc?

Latest FNCH News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.